The future of p53 research holds great promise. Advances in CRISPR technology and personalized medicine are likely to open new avenues for targeting p53 mutations. Understanding the complex network of interactions involving p53 and its downstream targets will be crucial for developing effective therapies. Continued research into the mechanisms of p53 regulation and mutation will help identify novel strategies for cancer prevention and treatment.
